Clinical Trials
2 trialsNCT00635193 2013-01-18
Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)
AbbVie
Phase 1/2 Completed
NCT00516841 2012-08-23
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
Facet Biotech
Phase 2 Terminated